These results were the first indication that DN T cells may participate in the prevention of a CD8+ T cell-driven T1D pathology, further lending support for a potential role for DN T cells toward the elimination of CD8+ T cells in vivo. This evidence concerns the gene CD8A and type 1 diabetes mellitus.